OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Shosaku� Nomura, Seitaro Omoto, Takehito Taniura, et al.
Diabetes Metabolic Syndrome and Obesity (2015), pp. 339-339
Open Access | Times Cited: 16
Shosaku� Nomura, Seitaro Omoto, Takehito Taniura, et al.
Diabetes Metabolic Syndrome and Obesity (2015), pp. 339-339
Open Access | Times Cited: 16
Showing 16 citing articles:
Chemokines in Prediabetes and Type 2 Diabetes: A Meta-Analysis
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Shi Wu Wen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 63
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Shi Wu Wen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 63
A Review on the Effects of New Anti-Diabetic Drugs on Platelet Function
Habib Yaribeygi, Stephen L. Atkin, Tannaz Jamialahmadi, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2019) Vol. 20, Iss. 3, pp. 328-334
Closed Access | Times Cited: 28
Habib Yaribeygi, Stephen L. Atkin, Tannaz Jamialahmadi, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2019) Vol. 20, Iss. 3, pp. 328-334
Closed Access | Times Cited: 28
Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates
Elhadi H. Aburawi, Juma Alkaabi, Taoufik Zoubeidi, et al.
PLoS ONE (2016) Vol. 11, Iss. 7, pp. e0159808-e0159808
Open Access | Times Cited: 27
Elhadi H. Aburawi, Juma Alkaabi, Taoufik Zoubeidi, et al.
PLoS ONE (2016) Vol. 11, Iss. 7, pp. e0159808-e0159808
Open Access | Times Cited: 27
Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis
Xin Liu, Peng Men, Yuhui Wang, et al.
Lipids in Health and Disease (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Xin Liu, Peng Men, Yuhui Wang, et al.
Lipids in Health and Disease (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 25
Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition
Maha H. Sharawy, Dalia H. El‐Kashef, Ahmed A. Shaaban, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108088-108088
Closed Access | Times Cited: 20
Maha H. Sharawy, Dalia H. El‐Kashef, Ahmed A. Shaaban, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108088-108088
Closed Access | Times Cited: 20
Plasma E-selectin levels can play a role in the development of diabetic retinopathy
Márta Kasza, Judit Meleg, Julianna Várdai, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2016) Vol. 255, Iss. 1, pp. 25-30
Closed Access | Times Cited: 23
Márta Kasza, Judit Meleg, Julianna Várdai, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2016) Vol. 255, Iss. 1, pp. 25-30
Closed Access | Times Cited: 23
Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up
Takashi Nakamura, Yoshitaka Iwanaga, Yuki Miyaji, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Takashi Nakamura, Yoshitaka Iwanaga, Yuki Miyaji, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Statins in relation to adiponectin: A significant association with clinical implications
Niki Katsiki, Christos S. Mantzoros
Atherosclerosis (2016) Vol. 253, pp. 270-272
Closed Access | Times Cited: 11
Niki Katsiki, Christos S. Mantzoros
Atherosclerosis (2016) Vol. 253, pp. 270-272
Closed Access | Times Cited: 11
Saxagliptin protects against hypoxia-induced damage in H9c2 cells
Lili Zhang, Xiaogui Qi, Guowei Zhang, et al.
Chemico-Biological Interactions (2019) Vol. 315, pp. 108864-108864
Closed Access | Times Cited: 8
Lili Zhang, Xiaogui Qi, Guowei Zhang, et al.
Chemico-Biological Interactions (2019) Vol. 315, pp. 108864-108864
Closed Access | Times Cited: 8
Sitagliptin mitigates oxidative stress and up-regulates mitochondrial biogenesis markers in Brown adipose tissues of high-fat diet fed obese mice through AMPK phosphorylation
Swati Prakash, Uddipak Rai, Ankit Uniyal, et al.
Obesity Medicine (2020) Vol. 19, pp. 100265-100265
Closed Access | Times Cited: 6
Swati Prakash, Uddipak Rai, Ankit Uniyal, et al.
Obesity Medicine (2020) Vol. 19, pp. 100265-100265
Closed Access | Times Cited: 6
Possibilities of Early Combination Therapy with Sitagliptin and Metformin in the Correction of Metabolic Disorders in Patients with Type 2 Diabetes and Obesity
Ametov Alexander Sergeevich, Gusenbekova Dinara Gadjimagomedovna, Butaeva Svetlana Garrievna, et al.
International Journal of Diabetes and Endocrinology (2020) Vol. 5, Iss. 1, pp. 1-1
Open Access | Times Cited: 3
Ametov Alexander Sergeevich, Gusenbekova Dinara Gadjimagomedovna, Butaeva Svetlana Garrievna, et al.
International Journal of Diabetes and Endocrinology (2020) Vol. 5, Iss. 1, pp. 1-1
Open Access | Times Cited: 3
Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study
Harmanjit Singh, Ravi Rohilla, Shivani Jaswal, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 19, Iss. 1, pp. 81-87
Closed Access | Times Cited: 1
Harmanjit Singh, Ravi Rohilla, Shivani Jaswal, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 19, Iss. 1, pp. 81-87
Closed Access | Times Cited: 1
Risk of Atherosclerosis Due to HMGB1-dependent Platelet-derived Microparticles in Patients with Type 2 Diabetes Mellitus
Shosaku� Nomura, Takehito Taniura, Jun Ichikawa, et al.
Clinical and Applied Thrombosis/Hemostasis (2024) Vol. 30
Open Access
Shosaku� Nomura, Takehito Taniura, Jun Ichikawa, et al.
Clinical and Applied Thrombosis/Hemostasis (2024) Vol. 30
Open Access
Effects of sitagliptin on serum lipid levels in patients with type 2 diabetes: a systematic review and meta-analysis
Li‐Da Wu, Nan Zhou, Jin-Yu Sun, et al.
Journal of Cardiovascular Medicine (2021) Vol. 23, Iss. 5, pp. 308-317
Closed Access | Times Cited: 3
Li‐Da Wu, Nan Zhou, Jin-Yu Sun, et al.
Journal of Cardiovascular Medicine (2021) Vol. 23, Iss. 5, pp. 308-317
Closed Access | Times Cited: 3
DPP-4 Inhibitors and Fat Metabolism in Patients with Type 2 Diabetes
Ametov As, D.G. Gusenbekova
InTech eBooks (2018)
Open Access | Times Cited: 2
Ametov As, D.G. Gusenbekova
InTech eBooks (2018)
Open Access | Times Cited: 2
[Sitagliptin inhibits lipopolysaccharide-induced inflammatory response in human gingival fibroblasts by blocking nuclear factor-κB signaling pathway]
Xiang Liu, Wenyan Kang, Lingling Shang, et al.
Huáxī kǒuqiāng yīxué zázhi (2021) Vol. 39, Iss. 2, pp. 153-163
Closed Access | Times Cited: 1
Xiang Liu, Wenyan Kang, Lingling Shang, et al.
Huáxī kǒuqiāng yīxué zázhi (2021) Vol. 39, Iss. 2, pp. 153-163
Closed Access | Times Cited: 1
